Gefitinib, Methotrexate and Methotrexate plus 5-Fluorouracil as palliative treatment in recurrent head and neck squamous cell carcinoma

Current Treatment Options for Metastatic Head and Neck Cancer

(2012) Katharine A. R. Price et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Management of Recurrent Head and Neck Cancer

(2011) Bruce E. Brockstein   DRUGS

Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent

(2011) Jacques Tortochaux et al.   RADIOTHERAPY AND ONCOLOGY

Optimal treatment for recurrent/metastatic head and neck cancer

(2010) J. B. Vermorken et al.   ANNALS OF ONCOLOGY

Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial

(2009) Fernando Rivera et al.   Expert Review of Anticancer Therapy

Phase III Study of Gefitinib Compared With Intravenous Methotrexate for Recurrent Squamous Cell Carcinoma of the Head and Neck

(2009) J. Simon W. Stewart et al.   JOURNAL OF CLINICAL ONCOLOGY